Tacrolimus trough level and oxidative stress in Tunisian kidney transplanted patients.

Tacrolimus oxidative stress post-transplantation trough level

Journal

Renal failure
ISSN: 1525-6049
Titre abrégé: Ren Fail
Pays: England
ID NLM: 8701128

Informations de publication

Date de publication:
Dec 2024
Historique:
medline: 12 2 2024
pubmed: 12 2 2024
entrez: 12 2 2024
Statut: ppublish

Résumé

The effect of tacrolimus (TAC) on oxidative stress after kidney transplantation (KT) is unclear. This study aimed to evaluate the influence of TAC trough levels of oxidative stress status in Tunisian KT patients during the post-transplantation period (PTP). A prospective study including 90 KT patients was performed. TAC whole-blood concentrations were measured by the microparticle enzyme immunoassay method and adjusted according to the target range. Plasma levels of oxidants (malondialdehyde (MDA) and advanced oxidation protein products (AOPP)) and antioxidants (ascorbic acid, glutathione (GSH), glutathione peroxidase (GPx), and superoxide dismutase (SOD)) were measured using spectrophotometry. The subjects were subdivided according to PTP into three groups: patients with early, intermediate, and late PT. According to the TAC level, they were subdivided into LL-TAC, NL-TAC, and HL-TAC groups. A decrease in MDA levels, SOD activity, and an increase in GSH levels and GPx activity were observed in patients with late PT compared to those with early and intermediate PT ( Our results have shown that in KT patients, despite the recovery of kidney function, the TAC reduced but did not normalize oxidative stress levels in long-term therapy, and the TAC effect significantly depends on the concentration used.

Sections du résumé

BACKGROUND UNASSIGNED
The effect of tacrolimus (TAC) on oxidative stress after kidney transplantation (KT) is unclear. This study aimed to evaluate the influence of TAC trough levels of oxidative stress status in Tunisian KT patients during the post-transplantation period (PTP).
METHODS UNASSIGNED
A prospective study including 90 KT patients was performed. TAC whole-blood concentrations were measured by the microparticle enzyme immunoassay method and adjusted according to the target range. Plasma levels of oxidants (malondialdehyde (MDA) and advanced oxidation protein products (AOPP)) and antioxidants (ascorbic acid, glutathione (GSH), glutathione peroxidase (GPx), and superoxide dismutase (SOD)) were measured using spectrophotometry. The subjects were subdivided according to PTP into three groups: patients with early, intermediate, and late PT. According to the TAC level, they were subdivided into LL-TAC, NL-TAC, and HL-TAC groups.
RESULTS UNASSIGNED
A decrease in MDA levels, SOD activity, and an increase in GSH levels and GPx activity were observed in patients with late PT compared to those with early and intermediate PT (
CONCLUSION UNASSIGNED
Our results have shown that in KT patients, despite the recovery of kidney function, the TAC reduced but did not normalize oxidative stress levels in long-term therapy, and the TAC effect significantly depends on the concentration used.

Identifiants

pubmed: 38345031
doi: 10.1080/0886022X.2024.2313863
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2313863

Auteurs

Mariam Ammar (M)

Department of Pharmacology, Faculty of Medicine, University of Sfax, Sfax, Tunisia.
Laboratory of Research of Pharmacology and Toxicology, University of Sfax, Sfax, Tunisia.
Faculty of Sciences of Sfax, University of Sfax, Sfax, Tunisia.

Soumaya Yaich (S)

Department of Nephrology, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.
Laboratory of Research of Renal Pathology, University of Sfax, Sfax, Tunisia.

Ahmed Hakim (A)

Department of Pharmacology, Faculty of Medicine, University of Sfax, Sfax, Tunisia.
Laboratory of Research of Pharmacology and Toxicology, University of Sfax, Sfax, Tunisia.

Hanen Ghozzi (H)

Department of Pharmacology, Faculty of Medicine, University of Sfax, Sfax, Tunisia.
Laboratory of Research of Pharmacology and Toxicology, University of Sfax, Sfax, Tunisia.

Zouheir Sahnoun (Z)

Department of Pharmacology, Faculty of Medicine, University of Sfax, Sfax, Tunisia.
Laboratory of Research of Pharmacology and Toxicology, University of Sfax, Sfax, Tunisia.

Mohamed Ben Hmida (M)

Department of Nephrology, Hedi Chaker University Hospital, University of Sfax, Sfax, Tunisia.
Laboratory of Research of Renal Pathology, University of Sfax, Sfax, Tunisia.

Khaled Zghal (K)

Department of Pharmacology, Faculty of Medicine, University of Sfax, Sfax, Tunisia.
Laboratory of Research of Pharmacology and Toxicology, University of Sfax, Sfax, Tunisia.

Lobna Ben Mahmoud (L)

Department of Pharmacology, Faculty of Medicine, University of Sfax, Sfax, Tunisia.
Laboratory of Research of Pharmacology and Toxicology, University of Sfax, Sfax, Tunisia.

Classifications MeSH